Logo image of SMIT

SCHMITT INDUSTRIES INC (SMIT) Stock Fundamental Analysis

NASDAQ:SMIT - US8068702005 - Common Stock

0.4195 USD
+0.04 (+10.39%)
Last: 1/13/2023, 8:00:03 PM
0.4075 USD
-0.01 (-2.86%)
After Hours: 1/13/2023, 8:00:03 PM
Fundamental Rating

1

Taking everything into account, SMIT scores 1 out of 10 in our fundamental rating. SMIT was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. SMIT has a bad profitability rating. Also its financial health evaluation is rather negative. SMIT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

SMIT had negative earnings in the past year.
In the past year SMIT has reported a negative cash flow from operations.
In multiple years SMIT reported negative net income over the last 5 years.
In the past 5 years SMIT reported 4 times negative operating cash flow.
SMIT Yearly Net Income VS EBIT VS OCF VS FCFSMIT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 -5M -10M

1.2 Ratios

SMIT has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SMIT Yearly ROA, ROE, ROICSMIT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -100 -200 -300 -400 -500

1.3 Margins

With an excellent Gross Margin value of 53.07%, SMIT belongs to the best of the industry, outperforming 89.68% of the companies in the same industry.
In the last couple of years the Gross Margin of SMIT has grown nicely.
SMIT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.04%
GM growth 5Y5.37%
SMIT Yearly Profit, Operating, Gross MarginsSMIT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 50 -50 -100 -150

More info and screens

0

2. Health

2.1 Basic Checks

SMIT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SMIT has more shares outstanding
SMIT has a better debt/assets ratio than last year.
SMIT Yearly Shares OutstandingSMIT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 1M 2M 3M 4M
SMIT Yearly Total Debt VS Total AssetsSMIT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M

2.2 Solvency

SMIT has an Altman-Z score of -2.54. This is a bad value and indicates that SMIT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -2.54, SMIT is doing worse than 92.06% of the companies in the same industry.
SMIT has a Debt/Equity ratio of 4.13. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 4.13, SMIT is not doing good in the industry: 95.24% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.13
Debt/FCF N/A
Altman-Z -2.54
ROIC/WACCN/A
WACC4.85%
SMIT Yearly LT Debt VS Equity VS FCFSMIT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 5M -5M 10M

2.3 Liquidity

SMIT has a Current Ratio of 0.69. This is a bad value and indicates that SMIT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of SMIT (0.69) is worse than 96.83% of its industry peers.
A Quick Ratio of 0.44 indicates that SMIT may have some problems paying its short term obligations.
SMIT has a worse Quick ratio (0.44) than 96.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.44
SMIT Yearly Current Assets VS Current LiabilitesSMIT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

SMIT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 57.23%, which is quite impressive.
The Revenue has grown by 229.42% in the past year. This is a very strong growth!
Measured over the past years, SMIT shows a decrease in Revenue. The Revenue has been decreasing by -4.42% on average per year.
EPS 1Y (TTM)57.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.53%
Revenue 1Y (TTM)229.42%
Revenue growth 3Y27.89%
Revenue growth 5Y-4.42%
Sales Q2Q%2405.75%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SMIT Yearly Revenue VS EstimatesSMIT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SMIT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SMIT Price Earnings VS Forward Price EarningsSMIT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SMIT Per share dataSMIT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SMIT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SCHMITT INDUSTRIES INC

NASDAQ:SMIT (1/13/2023, 8:00:03 PM)

After market: 0.4075 -0.01 (-2.86%)

0.4195

+0.04 (+10.39%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)12-09 2022-12-09/amc
Earnings (Next)12-13 2022-12-13/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners8.41%
Ins Owner Change0%
Market Cap1.62M
Analysts0
Price TargetN/A
Short Float %0%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B 2.68
P/tB 3.4
EV/EBITDA N/A
EPS(TTM)-0.92
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.34
FCFYN/A
OCF(TTM)-2.08
OCFYN/A
SpS4.77
BVpS0.16
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.07%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.04%
GM growth 5Y5.37%
F-Score3
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 4.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 228.03%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.69
Quick Ratio 0.44
Altman-Z -2.54
F-Score3
WACC4.85%
ROIC/WACCN/A
Cap/Depr(3y)167.52%
Cap/Depr(5y)101.47%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)229.42%
Revenue growth 3Y27.89%
Revenue growth 5Y-4.42%
Sales Q2Q%2405.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-89.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.96%
OCF growth 3YN/A
OCF growth 5YN/A